A Study to Evaluate First-line Ipilimumab + Nivolumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT06487156 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06487156
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-11
- Primary completion
- 2030-10-11
- Enrollment
- 404
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.